A Multiscale, Mechanism-Driven, Dynamic Model for the Effects of 5α-Reductase Inhibition on Prostate Maintenance

Open Access

Peer-reviewed

Research Article

Michael G. Zager ,

* E-mail: michael.zager@pfizer.com

Affiliation Pharmacokinetics, Dynamics and Metabolism, Worldwide Research and Development, Pfizer, Inc., San Diego, California, United States of America
⨯
Hugh A. Barton

Affiliation Pharmacokinetics, Dynamics and Metabolism, Worldwide Research and Development, Pfizer, Inc., Groton, Connecticut, United States of America
⨯

Reader Comments (0)

Prostate gland
Is the Subject Area "Prostate gland" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Androgens
Is the Subject Area "Androgens" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Castration
Is the Subject Area "Castration" applicable to this article?

Thanks for your feedback.
Cell proliferation
Is the Subject Area "Cell proliferation" applicable to this article?

Thanks for your feedback.
Dose prediction methods
Is the Subject Area "Dose prediction methods" applicable to this article?

Thanks for your feedback.
Pharmacokinetics
Is the Subject Area "Pharmacokinetics" applicable to this article?

Thanks for your feedback.